{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:43:21Z","timestamp":1792547001143,"version":"4.5.0"},"reference-count":44,"publisher":"The Society for Free Radical Research Japan","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Biochem. Nutr."],"published-print":{"date-parts":[[2011]]},"DOI":"10.3164\/jcbn.10-79","type":"journal-article","created":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T18:00:03Z","timestamp":1299002403000},"page":"107-111","source":"Crossref","is-referenced-by-count":201,"title":["The pathophysiology of non-steroidal anti-inflammatory drug (NSAID)-induced mucosal injuries in stomach and small intestine"],"prefix":"10.3164","volume":"48","author":[{"given":"Hirofumi","family":"Matsui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Shimokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanho","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichinosuke","family":"Hyodo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1739","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.05.030"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2&emsp;Higuchi K, Umegaki E, Watanabe T, and et al. Present status and strategy of NSAIDs-induced small bowel injury. J Gastroenterol 2009; 44: 879-888.","DOI":"10.1007\/s00535-009-0102-2"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.3164\/jcbn.SR09-58"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.3164\/jcbn.09-24"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.3164\/jcbn.09-103"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.3164\/jcbn.10-32"},{"key":"7","unstructured":"7&emsp;Del Valle J. Peptic ulcer disease and related disorders. eds. By Fauci, AS, Kasper, DL, Longo, DL, and et al, eds. Harrison&rsquo;s Principles of Internal Medicine 17th Edition, New York, McGraw-Hill Professional, 2008; 1855-1872."},{"key":"8","unstructured":"8&emsp;Cryer B, Spechler SJ. Peptic ulcer disease. eds. By Feldman, M, Friedman, LS and Brandt, LJ, Sleisenger and Fordtran&rsquo;s Gastrointestinal and Liver Disease 8th Edition, Philadelphia, Saunders, 2006; 1089-1110."},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v111.pm8690211"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2000.16510"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11&emsp;Laine L. Nonsteroidal anti-inflammatory drug gastropathy. Gastrointest Endosc Clin N Am 1996; 6: 489-504.","DOI":"10.1016\/S1052-5157(18)30351-9"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-007-0756-2"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2004.05.034"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(00)00287-9"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-4889(02)00171-4"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-005-2810-7"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.3109\/00365529509093280"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18&emsp;Bjarnason I, Hayllar J, MacPherson AJ, Russell AS. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 1993; 104: 1832-1847.","DOI":"10.1016\/0016-5085(93)90667-2"},{"key":"19","unstructured":"19&emsp;Feldman M. Ulcers of the small and large intestine, Philadelphia, Saunders, 2006; 2587-2597."},{"key":"20","unstructured":"20&emsp;Bjarnason I, Hayllar J. Early pathogenic events in NSAID-induced gastrointestinal damage. Ital J Gastroenterol, 1996; 28 Suppl 4: 19-22."},{"key":"21","unstructured":"21&emsp;Maity P, Bindu S, Choubey V, and et al. Lansoprazole protects and heals gastric mucosa from non-steroidal anti-inflammatory drug (NSAID)-induced gastropathy by inhibiting mitochondrial as well as Fas-mediated death pathways with concurrent induction of mucosal cell renewal. J Biol Chem 2008; 28: 14391-14401."},{"key":"22","unstructured":"22&emsp;Yoshida Y, Singh I, Darby CP. Effect of salicylic acid and calcium on mitochondrial functions. Acta Neurol Scand 1992; 85: 191-196."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23&emsp;Tomoda T, Takeda K, Kurashige T, Enzan H, Miyahara M. Acetylsalicylate (ASA)-induced mitochondrial dysfunction and its potentiation by Ca<sup>2+<\/sup>. Liver 1994; 14: 103-108.","DOI":"10.1111\/j.1600-0676.1994.tb00056.x"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24&emsp;De G&oacute;mez Puyou MT, Gavilanes M, G&oacute;mez-Puyou A, Ernster L. Control of activity states of heart mitochondrial ATPase. Role of the proton-motive force and Ca<sup>2+<\/sup>. Biochim Biophys Acta 1980; 592: 396-405.","DOI":"10.1016\/0005-2728(80)90087-0"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25&emsp;Jorgensen TG, Weis-Fogh US, Nielsen HH, Olesen HP. Salicylate- and aspirin-induced uncoupling of oxidative phosphorylation in mitochondria isolated from the mucosal membrane of the stomach. Scand J Clin Lab Invest 1976; 36: 649-654.","DOI":"10.1080\/00365517609054490"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26&emsp;Adams SS, Cobb R. A possible basis for the anti-inflammatory activity of salicylates and other non-hormonal anti-rheumatic drugs. Nature 1958; 181: 773-774.","DOI":"10.1038\/181773b0"},{"issue":"1","key":"27","first-page":"46","volume":"642","year":"1981","ISSN":"https:\/\/id.crossref.org\/issn\/0005-2728","issn-type":"print"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90708-4"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29&emsp;Omatsu T, Naito Y, Handa O, and et al. Involvement of reactive oxygen species in indomethacin-induced apoptosis of small intestinal epithelial cells. J Gastroenterol, 2009; 44 Suppl 19: 30-34.","DOI":"10.1007\/s00535-008-2293-3"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30&emsp;Bjarnason I, Smethurst P, Fenn CG, Lee CE, Menzies IS, Levi AJ. Misoprostol reduces indomethacin-induced changes in human small intestinal permeability. Dig Dis Sci 1989; 34: 407-411.","DOI":"10.1007\/BF01536263"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31&emsp;Aabakken L, Larsen S, Osnes M. Sucralfate for prevention of naproxen-induced mucosal lesions in the proximal and distal gastrointestinal tract. Scand J Rheumatol 1989; 18: 361-368.","DOI":"10.3109\/03009748909102097"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32&emsp;Aabakken L, Larsen S, Osnes M. Cimetidine tablets or suspension for the prevention of gastrointestinal mucosal lesions caused by non-steroidal, anti-inflammatory drugs. Scand J Rheumatol 1989; 18: 369-375.","DOI":"10.3109\/03009748909102098"},{"key":"33","unstructured":"33&emsp;Fang WF, Broughton A, Jacobson ED. Indomethacin-induced intestinal inflammation. Am J Dig Dis 1997; 22: 749-760."},{"key":"34","doi-asserted-by":"publisher","DOI":"10.1016\/0090-6980(77)90178-2"},{"key":"35","doi-asserted-by":"publisher","DOI":"10.1016\/0041-008X(70)90036-0"},{"key":"36","unstructured":"36&emsp;Brune K, Dietzel K, Nurnberg B, Schneider HT. Recent insight into the mechanism of gastrointestinal tract ulceration. Scand J Rheumatol Suppl 1987; 65: 135-140."},{"key":"37","doi-asserted-by":"crossref","unstructured":"37&emsp;Wallace JL, Keenan CM, Granger DN. Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil-dependent process. Am J Physiol 1990; 259: G462-G467.","DOI":"10.1152\/ajpgi.1990.259.3.G462"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38&emsp;Kunikata T, Araki H, Takeeda M, Kato S, Takeuchi K. Prostaglandin E prevents indomethacin-induced gastric and intestinal damage through different EP receptor subtypes. J Physiol Paris 2001; 95: 157-163.","DOI":"10.1016\/S0928-4257(01)00021-3"},{"key":"39","doi-asserted-by":"publisher","DOI":"10.1159\/000064419"},{"key":"40","unstructured":"40&emsp;Konaka A, Nishijima M, Tanaka A, Kunikata T, Kato S, Takeuchi K. Nitric oxide, superoxide radicals and mast cells in pathogenesis of indomethacin-induced small intestinal lesions in rats. J Physiol Pharmacol 1999; 50: 25-38."},{"key":"41","unstructured":"41&emsp;Takeuchi K, Tanaka A, Ohno R, Yokota A. Role of COX inhibition in pathogenesis of NSAID-induced small intestinal damage. J Physiol Pharmacol, 2003; 54 Suppl 4: 165-182."},{"key":"42","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v112.pm9041264"},{"key":"43","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(97)70225-7"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44&emsp;Somasundaram S, Sigthorsson G, Simpson RJ, and et al. Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibition of cyclooxygenase are required for the development of NSAID-enteropathy in the rat. Aliment Pharmacol Ther 2000; 14: 639-650.","DOI":"10.1046\/j.1365-2036.2000.00723.x"}],"container-title":["Journal of Clinical Biochemistry and Nutrition"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T16:25:51Z","timestamp":1712247951000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jcbn\/48\/2\/48_10-79\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.3164\/jcbn.10-79","relation":{},"ISSN":["1880-5086","0912-0009"],"issn-type":[{"value":"1880-5086","type":"electronic"},{"value":"0912-0009","type":"print"}],"subject":[],"published":{"date-parts":[[2011]]}}}